These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38957212)

  • 21. Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.
    Jung B; Embriaco N; Roux F; Forel JM; Demory D; Allardet-Servent J; Jaber S; La Scola B; Papazian L
    Intensive Care Med; 2010 May; 36(5):790-8. PubMed ID: 20217042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do we need biomarkers for the follow-up and shortening of antibiotic treatment duration?
    Dianti M; Luna CM
    Curr Opin Crit Care; 2018 Oct; 24(5):361-369. PubMed ID: 30124483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study.
    Póvoa P; Martin-Loeches I; Ramirez P; Bos LD; Esperatti M; Silvestre J; Gili G; Goma G; Berlanga E; Espasa M; Gonçalves E; Torres A; Artigas A
    J Crit Care; 2017 Oct; 41():91-97. PubMed ID: 28502892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of procalcitonin in the diagnosis of ventilator-associated pneumonia].
    Liao XL; Jin XD; Kang Y; Deng YY; Zhang ZW; Zhou Y; Zhang ZW; Liu C; Yin WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Mar; 22(3):142-5. PubMed ID: 20367902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury.
    Pelosi P; Barassi A; Severgnini P; Gomiero B; Finazzi S; Merlini G; d'Eril GM; Chiaranda M; Niederman MS
    Chest; 2008 Jul; 134(1):101-8. PubMed ID: 18403669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious complications after out-of-hospital cardiac arrest-A comparison between two target temperatures.
    Dankiewicz J; Nielsen N; Linder A; Kuiper M; Wise MP; Cronberg T; Erlinge D; Gasche Y; Harmon MB; Hassager C; Horn J; Kjaergaard J; Pellis T; Stammet P; Undén J; Wanscher M; Wetterslev J; Åneman A; Ullén S; Juffermans NP; Friberg H;
    Resuscitation; 2017 Apr; 113():70-76. PubMed ID: 27993631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD64 index on neutrophils can diagnose sepsis and predict 30-day survival in subjects after ventilator-associated pneumonia.
    Muzlovic I; Ihan A; Stubljar D
    J Infect Dev Ctries; 2016 Mar; 10(3):260-8. PubMed ID: 27031458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence.
    Strouvalis I; Routsi C; Adamopoulou M; Raftogiannis M; Renieris G; Orfanos SE; Kotanidou A; Sabracos L; Giamarellos-Bourboulis EJ
    Respirology; 2018 Oct; 23(10):942-949. PubMed ID: 29741298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia.
    Seligman R; Seligman BG; Teixeira PJ
    J Bras Pneumol; 2011; 37(4):495-503. PubMed ID: 21881740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current status of biomarkers for the diagnosis of nosocomial pneumonias.
    Salluh JIF; Souza-Dantas VC; Póvoa P
    Curr Opin Crit Care; 2017 Oct; 23(5):391-397. PubMed ID: 28759466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia-reperfusion injury and outcome.
    Annborn M; Dankiewicz J; Erlinge D; Hertel S; Rundgren M; Smith JG; Struck J; Friberg H
    Resuscitation; 2013 Jun; 84(6):782-7. PubMed ID: 23313427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia.
    Hillas G; Vassilakopoulos T; Plantza P; Rasidakis A; Bakakos P
    Eur Respir J; 2010 Apr; 35(4):805-11. PubMed ID: 19717486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and alveolar procalcitonin had a weak diagnostic value for ventilator-associated pneumonia in patients with pulmonary infection score ≥ 6.
    Shokri M; Ghasemian R; Bayani M; Maleh PA; Kamrani M; Sadeghi-Haddad-Zavareh M; Ebrahimpour S
    Rom J Intern Med; 2018 Mar; 56(1):9-14. PubMed ID: 28991776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial.
    Z Mazlan M; A H Ismail M; Ali S; Salmuna ZN; Wan Muhd Shukeri WF; Omar M
    Anaesthesiol Intensive Ther; 2021; 53(3):207-214. PubMed ID: 34006044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia.
    Dell'anna AM; Bini Viotti J; Beumier M; Orbegozo-Cortes D; Donadello K; Scolletta S; Vincent JL; Taccone FS
    Resuscitation; 2014 Jul; 85(7):932-8. PubMed ID: 24746786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?
    Sunnetcioglu A; Sunnetcioglu M; Adıyaman F; Binici I; Soyoral L
    Clin Respir J; 2017 Nov; 11(6):925-930. PubMed ID: 26683264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic value of HBP, PCT combined with APACHE Ⅱ score respectively in ventilator-associated pneumonia].
    Cheng Z; Yang YJ; Jing XG; Dai LL; Wang X; Jia LQ; Wang H; Jiang TC; An L; Liu M; Yang M; Li WF; Li Y
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1698-1702. PubMed ID: 31216814
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictors of treatment failure following early antibiotic discontinuation in culture-negative, ventilator-associated pneumonia: an observational study.
    Huu Thien Le B; Mai AT; Phan MD
    J Infect Dev Ctries; 2024 Jul; 18(7):1058-1065. PubMed ID: 39078791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial.
    Dahyot-Fizelier C; Frasca D; Lasocki S; Asehnoune K; Balayn D; Guerin AL; Perrigault PF; Geeraerts T; Seguin P; Rozec B; Elaroussi D; Cottenceau V; Guyonnaud C; Mimoz O;
    BMJ Open; 2018 Oct; 8(10):e021488. PubMed ID: 30341115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity.
    Lin Q; Fu F; Shen L; Zhu B
    Heart Lung; 2013; 42(2):139-45. PubMed ID: 23273657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.